Actavis to acquire Alpharma's Human Generics business

Actavis becomes one of top 5 global generics players

19-Oct-2005

Actavis Group announced that it has agreed to acquire the human generics business of the US listed pharmaceutical company, Alpharma Inc., for a total consideration of US$810 million in cash. The deal brings together two premier generic pharmaceutical businesses with complementary strengths in Europe and the US and represents a significant milestone in Actavis' goal to become one of the leading global companies within the sector.

The combination of Actavis' brand and geographic coverage in Europe and the US with Alpharma's attractive position in the US market and own label sales in key European markets is expected to generate substantial opportunities to drive revenue growth, provide significant synergies and create shareholder value for the enlarged Group. Following the acquisition Actavis will be among the five largest companies in generic pharmaceuticals worldwide, in terms of revenue.

The enlarged Group will have one of the broadest portfolios in the generics sector with over 600 products on the market. Alpharma's strong liquid product portfolio complements Actavis' strengths in oral solid-dose products and there is minimal overlap in both pipeline and portfolios for the US market.

Other news from the department business & finance

Most read news

More news from our other portals

Is artificial intelligence revolutionising chemistry?

Last viewed contents

Tosoh Bioscience – Separation & Purification Expands European Headquarters in Griesheim, Germany - "This new facility will allow us to better serve our customers and explore new chromatography techniques and applications"

Tosoh Bioscience – Separation & Purification Expands European Headquarters in Griesheim, Germany - "This new facility will allow us to better serve our customers and explore new chromatography techniques and applications"

Ajinomoto to Invest a Total of 15 Billion to Expand Production of Feed Grade Amino Acids and Umami Seasonings

New 'self-exploding' microcapsules could take sting out of drug delivery

Asphaltene analysis takes a giant step - Rice researchers develop accurate measure of aggregating particles that block oil production lines

Asphaltene analysis takes a giant step - Rice researchers develop accurate measure of aggregating particles that block oil production lines

Hybrid electro-biosystem upcycles carbon dioxide into energy-rich long-chain compounds - Upcycling CO₂ via electrochemical and metabolic engineering

Hybrid electro-biosystem upcycles carbon dioxide into energy-rich long-chain compounds - Upcycling CO₂ via electrochemical and metabolic engineering

Tiny Tubes for Biotransport - Researchers clarify cellular uptake mechanisms for carbon nanotubes

Albemarle Announces Custom Manufacturing Agreement With ExxonMobil Chemical - Agreement provides 15,000 metric tons per year of high viscosity polyalphaolefins production

Water-Soluble Warped Nanographene - Synthesis of a water-soluble warped nanographene and its application for photo-induced cell death

Water-Soluble Warped Nanographene - Synthesis of a water-soluble warped nanographene and its application for photo-induced cell death

Great interest in million-euro idea - Covestro funds best employee start-up team

New insight into thermoelectric materials may boost green technologies

New insight into thermoelectric materials may boost green technologies

ALTANA: Research and development investments increased significantly again - 2015 Results: ALTANA’s Sales Increase by 5 Percent

Hawaiian scientists take their test tubes surfing

Hawaiian scientists take their test tubes surfing